From zero to hero – the rise of Novo Nordisk's best-selling drug

Pharmaceutical giant Novo Nordisk is forever growing, but the drugs that used to drive sales have come and gone over the years. Today, one stands above the rest: quintuple blockbuster Ozempic.
Photo: Tidsvilde Stine/Ritzau Scanpix
Photo: Tidsvilde Stine/Ritzau Scanpix
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen

In five years, Novo Nordisk has created a multiple blockbuster drug in diabetes treatment Ozempic, which has been center stage in transforming the Danish pharmaceutical firm’s sales.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading